Drug – bio-affecting and body treating compositions – Whole live micro-organism – cell – or virus containing
Reexamination Certificate
2006-10-17
2006-10-17
Li, Q. Janice (Department: 1633)
Drug, bio-affecting and body treating compositions
Whole live micro-organism, cell, or virus containing
C435S325000
Reexamination Certificate
active
07122177
ABSTRACT:
The invention relates to developments in the treatment of diabetes in mammals. Particularly it relates to a method of preparing a xenotransplantable porcine islet preparation capable upon xenotransplantation of producing porcine insulin in an appropriate recipient mammal, the method including or comprising the steps of:(I) harvesting the pancreas of piglets at or near full term gestation, and(ii) extracting pancreatic β islet cells from the harvested pancreas wherein the islets (at least at some stage in the performance of the method) are exposed to nicotinamide.Further, the invention relates to a method of encapsulation of a xenotransplantable porcine islet preparation, and transplantation of such a preparation, or a capsule containing such a preparation, into an appropriate recipient mammal.
REFERENCES:
patent: 4850993 (1989-07-01), Champion et al.
patent: 5389535 (1995-02-01), Aebischer et al.
patent: 5516681 (1996-05-01), Naughton et al.
patent: 5550050 (1996-08-01), Holland et al.
patent: 5561108 (1996-10-01), Tsay et al.
patent: 5573528 (1996-11-01), Aebischer et al.
patent: 5762926 (1998-06-01), Gage et al.
patent: 5853385 (1998-12-01), Emerich et al.
patent: 5869463 (1999-02-01), Major et al.
patent: 5871767 (1999-02-01), Dionne et al.
patent: 5888705 (1999-03-01), Rubin et al.
patent: 5898066 (1999-04-01), Benowitz et al.
patent: 5968829 (1999-10-01), Carpenter
patent: 6001647 (1999-12-01), Peck et al.
patent: 6090400 (2000-07-01), Elliott
patent: 6146653 (2000-11-01), Elliott
patent: 6225310 (2001-05-01), Nielsen et al.
patent: 6365385 (2002-04-01), Opara
patent: 6432710 (2002-08-01), Boss et al.
patent: 6716246 (2004-04-01), Gonzalez
patent: 2003/0044391 (2003-03-01), Elliott et al
patent: 2004/0014212 (2004-01-01), Elliott et al.
patent: 2004/0033216 (2004-02-01), Elliott et al.
patent: 2004/0213768 (2004-10-01), Elliott et al.
patent: 2005/0042746 (2005-02-01), Garkavenko
patent: 2005/0106128 (2005-05-01), Elliott et al.
patent: 22893/95 (1995-11-01), None
patent: 81864/98 (1999-03-01), None
patent: 29135/99 (1999-10-01), None
patent: 2187803 (1995-10-01), None
patent: 2216055 (1999-03-01), None
patent: 0559307 (1993-09-01), None
patent: 0755258 (2002-01-01), None
patent: 2 369 828 (2002-06-01), None
patent: 250834 (1997-05-01), None
patent: 502473 (2000-01-01), None
patent: 337792 (2000-09-01), None
patent: 507616 (2000-10-01), None
patent: 515310 (2001-11-01), None
patent: WO95/28167 (1995-10-01), None
patent: WO 96/40178 (1996-12-01), None
patent: WO97/07668 (1997-03-01), None
patent: WO99/36565 (1999-07-01), None
patent: WO99/46982 (1999-09-01), None
patent: WO99/49734 (1999-10-01), None
patent: WO99/56770 (1999-11-01), None
patent: WO00/66188 (2000-11-01), None
patent: WO00/66188 (2000-11-01), None
patent: WO01/19182 (2001-03-01), None
patent: WO01/52871 (2001-07-01), None
patent: WO02/32437 (2002-04-01), None
patent: WO03/027270 (2003-04-01), None
patent: WO03/039566 (2003-05-01), None
patent: WO03/039566 (2003-05-01), None
Rayat et al, Diabetes 1998;47:1406-11.
Clark et al, Endocrinol 1990;126:1895-1903.
Saura et al, Neuroendocrinol Jan. 18, 1999;161-4.
Pu et al, Brit J Pharmacol 1996;118:1072-8.
Kallmann et al, Life Sciences 1992;51;671-8.
Elliott et al, Ann N Y Acad Sci. Nov. 30, 1993;696:333-41.
Ngo, in The Protein Folding Problem and Tertiary Structure Prediction, Merz et al. (eds.), Birkhauser Boston: Boston, MA, 1994.
Rudinger, in Peptide Hormones, Parsons (ed.), University Park Press: Baltimore, MD, pp. 1-7, 1976.
Sun “Porcine Pancreatic Islets: Isolation, Microencapsulation and Xenotransplantation”, Artificial Organs, 727-33 1993.
Maki “Porcine islet xenotransplantation utilizing a vascularized bioartificial pancreas” Annals of Transplantation, 69-71, 1997.
Lanza Biohybrid Artificial Pancreas: long-Term Function of Discordant Islet Xenografts in Streptozotocin Diabetic Rats, Transplantation, 1067-1072, 1993.
Sun et al “Normalisation of Diabetes in Spontaneously Diabetic Cynomologus Monkeys by Xenografts of Microencapsulated Porcine Islets without Immunosuppression” Journal of Clinical Investigation 1417-22 '96.
Calafiore, Riccardo. “Actual Perspectives in Biohybrid Artificial Pancreas for the Therapy of Type I, Insulin-Dependent Diabetes Mellitus”Diabetes/Metabolism Reviews.vol. 14, No. 4, Dec. 1998, pp. 315-324.
Brandhorst, Heide, et al. “Significant Progress in Porcine Islet Mass Isolation Utilizing Liberase HI for Enzymatic Low Temperature Pancreas Digestion”Transplantation.vol. 68, No. 3, Aug. 15, 1999, pp. 355-361.
Cavanagh, T.J., et al. “Improved Pig Islet Yield and Post-Culture Recovery Using Liberase PI Purified Enzyme Blend”Transplantation Proceedings.vol. 30, No. 2, Mar. 1998, p. 367.
Basta, G., et al. “Xenotransplantation of Microencapsulated Neonatal Porcine Islets (NIP) in Diabetic Recipients: Pre-clinical Trials”ACTA Diabetologica.vol. 37, No. 3, Sep. 2000, p. 145.
Barnes et al., “Influence of Recipient Oocyte Cell Cycle Stage on DNA Synthesis, Nuclear Envelope Breakdown, Chromosome Constitution and Development in Nuclear Transplant Bovine Embryos,”Mol. Reprod. Dev.,36:33-41, 1993.
Beal et al., “Differential Sparing of Somatostatin-Neuropeptide Y and Cholinergic Neurons following Striatal Excitotoxin Lesions,”Synapse,3(1):38-47, 1989.
Beattie et al., “Regulation of Proliferation and Differentiation of Human Fetal Pancreatic Islet Cells by Extracellular Matrix. Hepatocyte Growth Factor, and Cell-Cell Contact,”Diabetes,45:1223-1228, 1996.
Boquest et al., “Flow Cytometric Cell Cycle Analysis of Cultured Porcine Fetal Fibroblast Cells,”Biol. Reprod.,60:1013-1019, 1999.
Borlongan et al. “Locomotor and Passive Avoidance Deficits Following Occlusion of the Middle Cerebral Artery,”Physiology&Behavior,58:909-17, 1995.
Borlongan et al., “Elevated Body Swing Test: A New Behavioral Parameter for Rats with 6-Hydroxydopamine-Induced Hemiparkinsonism,”Neurosci.,15:5372-8, 1995.
Borlongan et al., “Striatal Dopamine-Mediated Motor Behavior is Altered Following Occlusion of the Middle Cerebral Artery,”Pharmacology Biochemistry and Behavior,52:225-9, 1995.
Borlongan et al. “Intercerebral Transplantation of Porcine Choroids Plexus Structural and Functional Neuroprotection in a Rodent Model of Stroke,”Stroke,35(9):2206-10, 2004.
Calafiore et al., “Effects of Alginate/Polyaminoacidic Coherent Microcapsule Transplantation in Adult Pigs,”Transplant. Proc.,4:2126-2167, 1997.
Calafiore et al., “Vascular Graft of Microencapsulated Human Pancreatic Islets in Non-Immunosuppressed Diabetic Recipients: Preliminary results,”Diab. Nutr. Metab.,4:45-48, 1991.
Calafiore et al., “Transplantation of Pancreatic Islets Contained in Minimal Volume Microcapsules in Diabetic High Mammalian,”Ann. N.Y. Acad. Sci.,875:219-232, 1999.
Campbell et al., “Cell Cycle Co-Ordination in Embryo Cloning by Nuclear Transfer,”Reviews Repro.,1:40-46, 1996.
Campbell et al., “Sheep Cloned by Nuclear Transfer From a Cultured Cell Line,”Nature,380:64-66, 1996.
Campbell et al., “Production of Live Lambs Following Nuclear Transfer of Cultured Embryonic Disc Cells,”Theriogenology,43:153-365; Abstract No. 181, 1995.
Campbell et al., “Improved Development of Blastocyst of Ovine Nuclear Transfer Embryos Reconstructed During the Presumptive S-phase of Enucleated Activated Oocytes,”Biol. Reprod.,50:1385-1394, 1994.
Campbell et al., “Nuclear-Cytoplasmic Interactions During the First Cell Cycle of Nuclear Transfer Reconstructed Bovine Embryos: Implications for Deoxyribonucleic Acid Replication and Development,”Biol. Reprod.,49:933-942, 1993.
Cheng, “Cationic Lipid Formulations for Intracellular Gene Delivery of Cystic Fibrosis Transmembrane Conductance Rugulator to Airway Epithelia,”Methods in Enzymology,292:697-717, 1998.
Cibelli et al., “Cloned Transgenic C
Basta Gusseppe
Calafiore Riccardo
Elliott Robert Bartlett
Diabcell PTY Ltd.
Haynes and Boone LLP
Li Q. Janice
Moore Mark D.
LandOfFree
Preparation and xenotransplantation of porcine islets does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Preparation and xenotransplantation of porcine islets, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Preparation and xenotransplantation of porcine islets will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3666224